Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Driscoll

Showing results (91-100 of 5,196) with videos related to

Pageof 520
Sort By:
Demographic Research|April 21, 2018
Adult outcomes of teen mothers across birth cohortsAnne K Driscoll
International Journal of Pharmaceutics|November 11, 2008
The pharmacopeial evolution of intralipid injectable emulsion in plastic containers: from a coarse to a fine dispersionDavid F Driscoll
Pediatric Clinics of North America|February 1, 1990
Evaluation of the cyanotic newbornD J Driscoll
Journal of Gerontological Nursing|November 24, 2015
Managing Heroin Addiction in an Outpatient Setting: A Case StudyKate Driscoll Malliarakis
Women & Health|October 27, 2015
Barriers and facilitators to cervical cancer screening in high incidence populations: A synthesis of qualitative evidenceSusan D Driscoll
World Review of Nutrition and Dietetics|December 5, 2014
Commercial lipid emulsions and all-in-one mixtures for intravenous infusion - composition and physicochemical propertiesDavid F Driscoll
Perspectives in Psychiatric Care|January 1, 1985
Maintenance medication for chronic schizophrenics: risk/benefit assessmentP L Driscoll
Frontiers in Public Health|August 15, 2022
Review of Lung Particle Overload, Rat Lung Cancer, and the Conclusions of the Edinburgh Expert Panel-It's Time to Revisit Cancer Hazard Classifications for Titanium Dioxide and Carbon BlackKevin E Driscoll
Anti-Cancer Agents in Medicinal Chemistry|March 2, 2011
The ubiquitin+proteasome protein degradation pathway as a therapeutic strategy in the treatment of solid tumor malignanciesJames J Driscoll, Alex Minter, Daniel A Driscoll, et al.
Annals of the New York Academy of Sciences|July 19, 2001
Degenerins. At the core of the metazoan mechanotransducer?N Tavernarakis, M Driscoll
Pageof 520

Showing results (91-100 of 5,196) with videos related to

Sort By:
Pageof 520
Demographic Research|April 21, 2018
Adult outcomes of teen mothers across birth cohortsAnne K Driscoll
International Journal of Pharmaceutics|November 11, 2008
The pharmacopeial evolution of intralipid injectable emulsion in plastic containers: from a coarse to a fine dispersionDavid F Driscoll
Pediatric Clinics of North America|February 1, 1990
Evaluation of the cyanotic newbornD J Driscoll
Journal of Gerontological Nursing|November 24, 2015
Managing Heroin Addiction in an Outpatient Setting: A Case StudyKate Driscoll Malliarakis
Women & Health|October 27, 2015
Barriers and facilitators to cervical cancer screening in high incidence populations: A synthesis of qualitative evidenceSusan D Driscoll
World Review of Nutrition and Dietetics|December 5, 2014
Commercial lipid emulsions and all-in-one mixtures for intravenous infusion - composition and physicochemical propertiesDavid F Driscoll
Perspectives in Psychiatric Care|January 1, 1985
Maintenance medication for chronic schizophrenics: risk/benefit assessmentP L Driscoll
Frontiers in Public Health|August 15, 2022
Review of Lung Particle Overload, Rat Lung Cancer, and the Conclusions of the Edinburgh Expert Panel-It's Time to Revisit Cancer Hazard Classifications for Titanium Dioxide and Carbon BlackKevin E Driscoll
Anti-Cancer Agents in Medicinal Chemistry|March 2, 2011
The ubiquitin+proteasome protein degradation pathway as a therapeutic strategy in the treatment of solid tumor malignanciesJames J Driscoll, Alex Minter, Daniel A Driscoll, et al.
Annals of the New York Academy of Sciences|July 19, 2001
Degenerins. At the core of the metazoan mechanotransducer?N Tavernarakis, M Driscoll
Pageof 520